Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2014, Vol. 34 Issue (7): 108-113    DOI: 10.13523/j.cb.20140717
    
Seed Cells
WANG Dian-liang
Tissue Engineering and Regenerative Medicine Laboratory, Department of Pharmacy, The Second Artillery General Hospital, Beijing 100088, China
Download: HTML   PDF(453KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Seed cell is another main research content of tissue engineering. To obtain enough quantity and quality of seed cell is necessary for research and application of tissue engineering. The seed cells for tissue engineering must have an ability of developing new tissue structure, which are mainly autologous, allogeneic and heterogenou and have different advantages and disadvantages when using. Some adult stem cells including hematopoietic stem cell, bone marrow stem cell, neural stem cell, adipose-derived stem cell and skin stem cell are important seed cells for no ethic disputes and relatively simple developing differentiation conditions, etc. Human embryonic stem cell and its tissue engineering still need a long way to go if they are applied in clinical medicine. Other cells can also be used as tissue engineering seed cells, including endothelial cells, epithelial cells, fibroblast cells, bone cells, osteoblast cells, horn cells, preadipose cells, adipose cells, tendon cells, etc. These cells are differentiated and have a limited ability of division but still applied in tissue engineering. Ideal seed cells have certain standards.



Key wordsTissue engineering      Seed cell      Somatic cell      Stem cell      Autogenous cell     
Received: 19 June 2014      Published: 25 July 2014
ZTFLH:  Q819  
Cite this article:

WANG Dian-liang. Seed Cells. China Biotechnology, 2014, 34(7): 108-113.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20140717     OR     https://manu60.magtech.com.cn/biotech/Y2014/V34/I7/108


[1] Liu X Y, Chen J, Zhou Q, et al. In vitro tissue engineering of lamellar cornea using human amniotic epithelial cells and rabbit cornea stroma. Int J Ophthalmol, 2013,6(4): 425-429.

[2] Mungadi I A. Bioengineering tissue for organ repair, regeneration and renewal. J Surg Tech Case Rep, 2012, 4(2): 77-78.

[3] Tang H, Wu B, Qin X, et al. Tissue engineering rib with the incorporation of biodegradable polymer cage and BMSCs/decalcified bone: an experimental study in a canine model. J Cardiothorac Surg, 2013, 8: 133.

[4] Kang J W, Koo H C, Hwang S Y,et al. Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells. J Vet Sci, 2012,13(1): 23-31.

[5] Sabapathy V, Ravi S, Srivastava V, et al. Long-term cultured human term placenta-derived mesenchymal stem cells of maternal origin displays plasticity. Stem Cells Int, 2012, 2012: 174328.

[6] Chamberlain M D, Gupta R, Sefton M V. Bone marrow-derived mesenchymal stromal cells enhance chimeric vessel development driven by endothelial cell-coated microtissues. Tissue Eng Part A, 2012, 18(3-4): 285-294.

[7] Friedenstein A J, Chailakhyan R K, Gerasimov U V. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet, 1987, 20(3):263-272.

[8] Estes B T, Diekman B O, Gimble J M, et al. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc, 2010,5(7):1294-1311.

[9] Zuk P A.Stem cell research has only just begun.Science, 2001, 13;293(5528):211-212.

[10] Eriksson P S, Perfilieva E, Björk-Eriksson T, et al. Neurogenesis in the adult human hippocampus.Nat Med, 1998,4(11):1313-1317.

[11] Wang D, Liu W, Han B, et al. The bioreactor: a powerful tool for large-scale culture of animal cells. Current Pharmaceutical Biotechnology, 2005, 6(5):35-41.

[12] Herring M, Gardner A, Glover J. A single-staged technique for seeding vascular grafts with autogenous endothelium. J Surgery, 1978, 84(4) :498-504.

[1] QIAN Yu,DING Xiao-yu,LIU Zhi-qiang,YUAN Zeng-qiang. An Efficient Monoclonal Establishment Method of Genetically Modified Human Pluripotent Stem Cells[J]. China Biotechnology, 2021, 41(8): 33-41.
[2] LI Kai-xiu,SI Wei. Progress in the Treatment of Inflammatory Bowel Diseases by Exosomes Derived from Mesenchymal Stem Cells[J]. China Biotechnology, 2021, 41(7): 66-73.
[3] WANG Yu-xuan,CHEN Ting,ZHANG Yong-liang. Research Progress on the Biological Function of MiR-148[J]. China Biotechnology, 2021, 41(7): 74-80.
[4] ZHU Shuai,JIN Ming-jie,YANG Shu-lin. A Review on Applications of 3D Bioprinting in Cartilage Tissue Regeneration Engineering[J]. China Biotechnology, 2021, 41(5): 65-71.
[5] ZHAO Jiu-mei,WANG Zhe,LI Xue-ying. Role of Signal Pathways and Related Factors Regulating Cartilage Formation in Bone Differentiation of Bone Marrow Mesenchymal Stem Cells[J]. China Biotechnology, 2021, 41(10): 62-72.
[6] CHEN Fei,WANG Xiao-bing,XU Zeng-hui,QIAN Qi-jun. Molecular Mechanism and Clinical Research Progress of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus[J]. China Biotechnology, 2020, 40(7): 59-69.
[7] YU Xing-ge,LIN Kai-li. The Application of Biomaterials Based on Natural Hydrogels in Bone Tissue Engineering[J]. China Biotechnology, 2020, 40(5): 69-77.
[8] DAI Qi-nan,ZHANG Jing-hong. Advances in Molecular Mechanisms Related to Tumor Multi-drug Resistance, Autophagy, DNA Repair and Tumor Stem Cells[J]. China Biotechnology, 2020, 40(4): 69-77.
[9] WANG Yuan-dou,SU Feng,LI Su-ming. Research Progress of Photocrosslinked Hydrogel in Tissue Engineering[J]. China Biotechnology, 2020, 40(4): 91-96.
[10] YUAN Ya-kun,LIU Guang-yang,LIU Yong-jun,XIE Ya-fang,WU Hao. Comparison of Research and Clinical Transformation on Mesenchymal Stem Cells between China and the US[J]. China Biotechnology, 2020, 40(4): 97-107.
[11] YANG Dan,TIAN Hai-shan,LI Xiao-kun. Research Progress of Fibroblast Growth Factor 5[J]. China Biotechnology, 2020, 40(3): 117-124.
[12] YAN Ge,QIAO Wei-hua,CAO Hong,SHI Jia-wei,DONG Nian-guo. Application of Surface Modification of Polydopamine in Tissue Engineering[J]. China Biotechnology, 2020, 40(12): 75-81.
[13] QIU Dan-dan,LU Cai-xia,DAI Jie-jie. Application of Hepatocyte-like Cells Derived from Induced Pluripotent Stem Cells in HCV Infection Model[J]. China Biotechnology, 2020, 40(11): 67-72.
[14] CHEN Li-jun,QU Jing-jing,XIANG Charlie. Therapeutic Potentials, Clinical Studies, and Application Prospects of Mesenchymal Stem Cells in 2019 Novel Coronavirus (COVID-19)[J]. China Biotechnology, 2020, 40(11): 43-55.
[15] ZHU Yongzhao,TAO Jin,REN Meng-meng,XIONG Ran,HE Ya-qin,ZHOU Yu,LU Zhen-hui,DU Yong,YANG Zhi-hong. Autophagy Protects Against Apoptosis of Human Placental Mesenchymal Stem Cells of Fetal Origin Induced by Tumor Necrosis Fator-α[J]. China Biotechnology, 2019, 39(9): 62-67.